MetLife Investment Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2855 |
|
|
2024
Q2 | – | Sell |
-149
| Closed | -$155K | – | 2885 |
|
|
2024
Q1 | $155K | Hold |
149
| – | – | ﹤0.01% | 2332 |
|
|
2023
Q4 | $118K | Hold |
149
| – | – | ﹤0.01% | 2523 |
|
|
2023
Q3 | $70.9K | Hold |
149
| – | – | ﹤0.01% | 2758 |
|
|
2023
Q2 | $89.7K | Hold |
149
| – | – | ﹤0.01% | 2742 |
|
|
2023
Q1 | $105K | Hold |
149
| – | – | ﹤0.01% | 2527 |
|
|
2022
Q4 | $153K | Buy |
+149
| New | +$153K | ﹤0.01% | 2408 |
|